Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- GSK and Tres Cantos Open Lab Foundation announce additional £5m funding for open innovation research in diseases impacting the developing world
- Trelegy Ellipta receives positive CHMP opinion supporting expanded COPD indication in Europe
- ViiV Healthcare submits regulatory application to European Medicines Agency for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV
Tweets from GSK
-
GSK @GSK
We know early science can lead to breakthroughs for global health. That is why we have committed an additional £5m to support the Tres Cantos Open Lab Foundation, a GSK-founded independent charity
about 9 hours ago -
GSK @GSK
Delighted that our partnership with @savechildrenuk has been voted most admired partnership for the third consecutive year in the C&E Corporate-NGO Partnerships Barometer 🙌@MannyAmadii
about 11 hours ago -
GSK @GSK
The way to beat asthma: targeted treatment. Go #BehindTheScience to find out more about how our scientists are looking into new ways to understand asthma, to help patients #LiveEveryBreath gsk.to/2xwkdVG
about 12 hours ago
